Corporate News2023
- Dec. 11, 2023 NROlympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
- Dec. 07, 2023 NRVesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
- Nov. 30, 2023 NROlympus's Net-Zero Targets Approved by SBTi
- Oct. 31, 2023 NROlympus and Terumo Announce Change in Form of Contract
- Oct. 03, 2023 NROlympus Names Dr. John de Csepel as Chief Medical Officer
- Aug. 09, 2023 NRNotice of Stock Change of Olympus Terumo Biomaterials
- Jul. 20, 2023 NROlympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
- Jul. 04, 2023 NROlympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
- Jun. 05, 2023 NROlympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
- May. 29, 2023 NROlympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
- May. 12, 2023 NROlympus Outlines Core Priorities Behind Refreshed Medical Strategy
- Apr. 03, 2023 NROlympus Announces Changes to Executive Officer Positions
- Mar. 29, 2023 InfoOlympus Selected for two consecutive years as a Supplier Engagement Leader 2022, the Highest Rating in the CDP Supplier Engagement Rating
- Mar. 01, 2023 NROlympus Certified as a 2023 Sports Yell Company by the Japan Sports Agency
- Feb. 24, 2023 NROlympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd,
- Feb. 17, 2023 NROlympus Donates for Turkey and Syria Earthquake Relief